Ultime notizie per Eltek (NASDAQ:ELTK) Azioni

Eltek

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

Eltek Ltd

Eltek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTK#NASDAQ">ELTK</a>) is preparing to release its quarterly earnings on Tuesday, 2024-11-19. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Eltek to report an earnings per share (EPS) of $0.31.
The announcement from Eltek is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company missed EPS by $0.14, leading to a 0.6% drop in the share price the following trading session.
Here's a look at Eltek's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.25</td>
<td>0.26</td>
<td>0.31</td>
<td>0.31</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.11</td>
<td>0.27</td>
<td>0.22</td>
<td>0.36</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>4.0%</td>
<td>-0.0%</td>
<td>11.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1731945683_0.png" alt="eps graph" />
<h3>Tracking Eltek's Stock Performance</h3>
Shares of Eltek were trading at $11.01 as of November 15. Over the last 52-week period, shares are down 18.96%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/ELTK/earnings">To track all earnings releases for Eltek visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

ELTK

Examining the Future: Eltek's Earnings Outlook

News

Contracts

Eltek Receives Orders Totaling $3.5M From Two Defense Customers

WIIM

Eltek shares are trading lower after the company reported worse-than-expected Q2 financial results.

Eltek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTK#NASDAQ">ELTK</a>) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.25 by 56 percent. This is a 50 percent decrease over earnings of $0.22 per share from the same period last year. The company reported quarterly sales of $10.47 million which missed the analyst consensus estimate of $11.90 million by 12.05 percent. This is a 5.23 percent decrease over sales of $11.04 million the same period last year.

Earnings Misses

Eltek Q2 EPS $0.11 Misses $0.25 Estimate, Sales $10.47M Miss $11.90M Estimate

Eltek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTK#NASDAQ">ELTK</a>) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.26 by 3.85 percent. This is unchanged from the same period last year. The company reported quarterly sales of $11.78 million which missed the analyst consensus estimate of $12.00 million by 1.81 percent. This is a 2.73 percent increase over sales of $11.47 million the same period last year.

Earnings Beats

Eltek Q1 EPS $0.27 Beats $0.26 Estimate, Sales $11.78M Miss $12.00M Estimate

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday.
The Dow traded up 0.08% to 38,753.49&nbsp;while the NASDAQ fell 0.20% to 16,052.34. The S&amp;P 500 also fell, dropping, 0.14% to 5,116.66.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37578817/cramer-says-this-healthcare-stock-can-go-higher-calls-manhattan-associates-a-winner"> Cramer Says This Healthcare Stock Can Go Higher, Calls Manhattan Associates &#39;A Winner&#39;</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Materials shares jumped by 0.9% on Monday.
In trading on Monday, industrials shares fell by 0.8%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
EQT Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eqt#NYSE">EQT</a>) announced that it entered into a definitive merger agreement to acquire Equitrans Midstream Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etrn#NYSE">ETRN</a>).
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) shares shot up 22% to $7.80 following a report suggesting Hillhouse and Boyu are in talks to invest in the company&#39;s Southeast Asia data center business.
Shares of Fangdd Network Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duo#NASDAQ">DUO</a>) got a boost, surging 20% to $0.7234 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a>
Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) shares were also up, gaining 22% to $2.6550 after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Eltek Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eltk#NASDAQ">ELTK</a>) shares dropped 22% to $10.80 after the company announced downbeat quarterly earnings.
Shares of Genie Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gne#NYSE">GNE</a>) were down 10% to $16.98 following fourth-quarter results.
Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) was down, falling 20% to $7.89. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.
Also Check This Out:<a href="https://www.benzinga.com/news/24/03/37584146/top-5-risk-off-stocks-that-may-plunge-this-quarter"> Top 5 Risk Off Stocks That May Plunge This Quarter</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 0.2% to $77.84 while gold traded up 0.1% at $2,186.40.
Silver traded up 0.6% to $24.69 on Monday while copper rose 0.9% to $3.9275.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mostly lower today. The eurozone&rsquo;s STOXX 600 fell 0.35%, London&rsquo;s FTSE 100 rose 0.12% while Spain&rsquo;s IBEX 35 Index rose 0.19% The German DAX fell 0.38% French CAC 40 fell 0.10% while Italy&rsquo;s FTSE MIB Index fell 0.27%.
Spanish retail trade rose by 0.3% year-over-year in January versus a revised 2.7% gain in the previous month.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Monday, with Japan&rsquo;s Nikkei 225 dipping 2.19%, Hong Kong&rsquo;s Hang Seng Index gaining 1.43%, China&rsquo;s Shanghai Composite Index gaining 0.74% and India&rsquo;s S&amp;P BSE Sensex falling 0.81%.
Chinese vehicle sales dipped by 19.9% year-over-year to 1.58 million units in February versus a 47.9% surge in the prior month. Japanese machine tool orders declined by 8% year-over-year to JPY 114,154 million in February. Japan&#39;s GDP expanded by 0.1% quarter-over-quarter in the fourth quarter versus a 0.8% contraction in the third quarter.
&nbsp;
<h3>Economics</h3>
&nbsp;
No economic report of significance is due for Monday
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37578904/how-to-earn-500-a-month-from-calavo-growers-ahead-of-q1-earnings"> How To Earn $500 A Month From Calavo Growers Ahead Of Q1 Earnings</a>

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

Markets

Trading Ideas

ETRN

LXRX

VTYX

Dow Turns Higher; GDS Holdings Shares Climb

Shares of Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) rose sharply during Monday&rsquo;s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients.
Mesoblast shares jumped 13.4% to $2.4399 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Kidpik Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pik#NASDAQ">PIK</a>) gained 238% to $9.15. Kidpik recently announced a 1-for 5 reverse stock split.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) shares surged 149% to $2.6450.</li>
<li>TRxADE HEALTH, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meds#NASDAQ">MEDS</a>) gained 114.6% to $17.26. TRxADE Health recently announced a special cash dividend of $8 per share.</li>
<li>Fangdd Network Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duo#NASDAQ">DUO</a>) shares climbed 108% to $1.2593 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a>.</li>
<li>GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) shares gained 23.7% to $7.93 following a report suggesting Hillhouse and Boyu are in talks to invest in the company&#39;s Southeast Asia data center business.</li>
<li>Solidion Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sti#NASDAQ">STI</a>) rose 23.3% to $0.9620.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kc#NASDAQ">KC</a>) shares gained 23.1% to $3.31. Kingsoft Cloud is expected to report fourth-quarter financial results on March 20, 2024.</li>
<li>EHang Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eh#NASDAQ">EH</a>) gained 21.7% to $13.89. EHang Holdings is expected to release its unaudited financial results for the fourth quarter on March 15, 2024.</li>
<li>Bally&#39;s Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/baly#NYSE">BALY</a>) gained 21.5% to $12.90. Standard General delivered a non-binding letter to the board of directors of Bally&#39;s proposing a transaction under which it would acquire all of the outstanding shares of common stock for $15/share, not currently owned by the company.</li>
<li>Rail Vision Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvsn#NASDAQ">RVSN</a>) climbed 21.2% to $3.43. Rail Vision received an order from a Class 1 US railroad company for its AI-based safety system.</li>
<li>Marpai, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrai#NASDAQ">MRAI</a>) gained 18.7% to $2.0899.</li>
<li>bioAffinity Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biaf#NASDAQ">BIAF</a>) climbed 18.3% to $1.81.</li>
<li>Lixiang Education Holding Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxeh#NASDAQ">LXEH</a>) gained 15.6% to $4.8797.</li>
<li>Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) jumped 13.4% to $2.4650 after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.</li>
<li>NWTN Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nwtn#NASDAQ">NWTN</a>) gained 13.4% to $4.8082.</li>
<li>Pulse Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plse#NASDAQ">PLSE</a>) rose 12.7% to $10.86. Pulse Biosciences announced FDA 510(k) clearance for Cellfx NSPFA Percutaneous Electrode System.</li>
<li>Bilibili Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bili#NASDAQ">BILI</a>) gained 12.7% to $12.55 after JP Morgan upgraded the stock from Underweight to Neutral and raised its price target from $10 to $11. The stock is also gaining amid overall China strength following the annual National People&#39;s Congress event.</li>
<li>Graphite Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grph#NASDAQ">GRPH</a>) climbed 11.7% to $3.5080. Graphite Bio declared a special dividend in connection with proposed merger with Lenz Therapeutics.</li>
<li>STAAR Surgical Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/staa#NASDAQ">STAA</a>) jumped 10% to $39.45 after Stifel upgraded the stock from Hold to Buy and raised its price target from $30 to $50.</li>
<li>VNET Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnet#NASDAQ">VNET</a>) rose 9.8% to $1.68.</li>
<li>Moderna, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrna#NASDAQ">MRNA</a>) gained 9.2% to $112.51.</li>
<li>Ituran Location and Control Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itrn#NASDAQ">ITRN</a>) climbed 7.8% to $28.42.</li>
<li>NuScale Power Corporation(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) gained 7% to $5.87. NuScale Power is expected to release fourth quarter results on March 14, 2024.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) gained 4.7% to $1,492.07 amid continued strength in Bitcoin.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Jeffs&#39; Brands Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jfbr#NASDAQ">JFBR</a>) fell 45.2% to $0.8650.</li>
<li>Eltek Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eltk#NASDAQ">ELTK</a>) shares fell 20.9% to $11.00 after the company announced downbeat quarterly earnings.</li>
<li>CERo Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cero#NASDAQ">CERO</a>) declined 22% to $3.0822 after jumping 28% on Friday. CERo Therapeutics recently announced the publication of preclinical research analyzing CER-1236 in targeting Acute Myelogenous Leukemia tumor cells from human patients.</li>
<li>The Real Good Food Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgf#NASDAQ">RGF</a>) fell 19.7% to $0.5536.</li>
<li>Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) dipped 18.5% to $8.09. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.</li>
<li>Lytus Technologies Holdings PTV. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyt#NASDAQ">LYT</a>) fell 15.3% to $6.78 after declining 8% on Friday. Lytus Technologies, last week, announced the launch of Lytus Cloud.</li>
<li>Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) declined 15.3% to $0.0727.</li>
<li>MoneyLion Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ml#NYSE">ML</a>) fell 15% to $63.36.</li>
<li>Semilux International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/selx#NASDAQ">SELX</a>) fell 14.8% to $1.4403 after jumping 69% on Friday.</li>
<li>Lytus Technologies Holdings PTV. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyt#NASDAQ">LYT</a>) fell 14.6% to $6.83.</li>
<li>Barnes &amp; Noble Education, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bned#NYSE">BNED</a>) dipped 13.8% to $0.7832. Barnes &amp; Noble Education recently rescheduled its third quarter fiscal year 2024 earnings release.</li>
<li>Psyence Biomedical Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbm#NASDAQ">PBM</a>) fell 13.4% to $1.8272 after jumping 66% on Friday. The company recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study.</li>
<li>Immuron Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imrn#NASDAQ">IMRN</a>) shares tumbled 12.5% to $3.3252 after dipping 16% on Friday.</li>
<li>Genie Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gne#NYSE">GNE</a>) fell 12% to $16.67 following fourth-quarter results.</li>
<li>Nanobiotix S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbtx#NASDAQ">NBTX</a>) dipped 9.8% to $6.35.</li>
<li>Avenue Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atxi#NASDAQ">ATXI</a>) fell 8.9% to $0.1749 after surging 10% on Friday.</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) dipped 8.8% to $1,039.60.</li>
<li>MannKind Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnkd#NASDAQ">MNKD</a>) declined 8.7% to $4.81. MannKind announced initial meal challenge data from INHALE-3 Phase 4 U.S. trial comparing afrezza head-to-head with multiple daily injections and insulin pumps.</li>
<li>Poseida Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pstx#NASDAQ">PSTX</a>) fell 8.1% to $3.74.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37584162/wall-streets-most-accurate-analysts-say-buy-these-3-energy-stocks-with-over-3-dividend-y"> Wall Street&#39;s Most Accurate Analysts Say Buy These 3 Energy Stocks With Over 3% Dividend Yields</a>

Movers

ATXI

BALY

BIAF

BILI

BNED

CERO

EGOX

GRPH

IMRN

ITRN

JFBR

LXEH

MEDS

MESO

MNKD

MRAI

MRNA

MSTR

NBTX

NWTN

PLSE

PSTX

RVSN

SELX

SMCI

STAA

TCBP

VNET

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

U.S. stocks traded lower midway through trading, with the Dow Jones index dipping over 50 points on Monday.
The Dow traded down 0.16% to 38,662.09 while the NASDAQ fell 0.26% to 16,043.75. The S&amp;P 500 also fell, dropping, 0.27% to 5,110.11.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37578817/cramer-says-this-healthcare-stock-can-go-higher-calls-manhattan-associates-a-winner"> Cramer Says This Healthcare Stock Can Go Higher, Calls Manhattan Associates &#39;A Winner&#39;</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Materials shares jumped by 0.3% on Monday.
In trading on Monday, industrials shares fell by 1.1%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
EQT Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eqt#NYSE">EQT</a>) announced that it entered into a definitive merger agreement to acquire Equitrans Midstream Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etrn#NYSE">ETRN</a>).
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) shares shot up 21% to $7.77 following a report suggesting Hillhouse and Boyu are in talks to invest in the company&#39;s Southeast Asia data center business.
Shares of Fangdd Network Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duo#NASDAQ">DUO</a>) got a boost, surging 48% to $0.8952 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a>
Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) shares were also up, gaining 19% to $2.5790 after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Eltek Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eltk#NASDAQ">ELTK</a>) shares dropped 21% to $11.05 after the company announced downbeat quarterly earnings.
Shares of Genie Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gne#NYSE">GNE</a>) were down 11% to $16.93 following fourth-quarter results.
Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) was down, falling 19% to $8.07. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.
Also Check This Out:<a href="https://www.benzinga.com/news/24/03/37584146/top-5-risk-off-stocks-that-may-plunge-this-quarter"> Top 5 Risk Off Stocks That May Plunge This Quarter</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded up 0.2% to $78.17 while gold traded up 0.2% at $2,189.80.
Silver traded up 0.3% to $24.615 on Monday while copper rose 0.4% to $3.9085.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mostly lower today. The eurozone&rsquo;s STOXX 600 fell 0.57%, London&rsquo;s FTSE 100 fell 0.30% while Spain&rsquo;s IBEX 35 Index rose 0.10% The German DAX fell 0.63% French CAC 40 fell 0.38% while Italy&rsquo;s FTSE MIB Index fell 0.53%.
Spanish retail trade rose by 0.3% year-over-year in January versus a revised 2.7% gain in the previous month.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Monday, with Japan&rsquo;s Nikkei 225 dipping 2.19%, Hong Kong&rsquo;s Hang Seng Index gaining 1.43%, China&rsquo;s Shanghai Composite Index gaining 0.74% and India&rsquo;s S&amp;P BSE Sensex falling 0.81%.
Chinese vehicle sales dipped by 19.9% year-over-year to 1.58 million units in February versus a 47.9% surge in the prior month. Japanese machine tool orders declined by 8% year-over-year to JPY 114,154 million in February. Japan&#39;s GDP expanded by 0.1% quarter-over-quarter in the fourth quarter versus a 0.8% contraction in the third quarter.
&nbsp;
<h3>Economics</h3>
&nbsp;
No economic report of significance is due for Monday.
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37578904/how-to-earn-500-a-month-from-calavo-growers-ahead-of-q1-earnings"> How To Earn $500 A Month From Calavo Growers Ahead Of Q1 Earnings</a>

Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump

Eltek shares are trading lower after the company reported worse-than-expected Q4 financial results.

U.S. stocks traded lower this morning, with the Dow Jones index dipping around 100 points on Monday.
Following the market opening Monday, the Dow traded down 0.27% to 38,618.51 while the NASDAQ fell 0.16% to 16,058.93. The S&amp;P 500 also fell, dropping, 0.24% to 5,111.38.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37578817/cramer-says-this-healthcare-stock-can-go-higher-calls-manhattan-associates-a-winner"> Cramer Says This Healthcare Stock Can Go Higher, Calls Manhattan Associates &#39;A Winner&#39;</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Materials shares jumped by 0.6% on Monday.
In trading on Monday, information technology shares fell by 0.9%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Eltek Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eltk#NASDAQ">ELTK</a>) posted downbeat earnings for its fourth quarter on Monday.
Eltek posted quarterly earnings of 22 cents per share, missing market estimates of 31 cents per share.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Kidpik Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pik#NASDAQ">PIK</a>) shares shot up 254% to $9.57. Kidpik recently announced a 1-for 5 reverse stock split.
Shares of Fangdd Network Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duo#NASDAQ">DUO</a>) got a boost, surging 95% to $1.1780 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a>
TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) shares were also up, gaining 69% to $1.79.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Eltek Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eltk#NASDAQ">ELTK</a>) shares dropped 22% to $10.90 after the company announced downbeat quarterly earnings.
Shares of Jeffs&#39; Brands Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jfbr#NASDAQ">JFBR</a>) were down 24% to $1.20.
CERo Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cero#NASDAQ">CERO</a>) was down, falling 21% to $3.12 after jumping 28% on Friday. CERo Therapeutics recently announced the publication of preclinical research analyzing CER-1236 in targeting Acute Myelogenous Leukemia tumor cells from human patients.
Also Check This Out:<a href="https://www.benzinga.com/news/24/03/37584146/top-5-risk-off-stocks-that-may-plunge-this-quarter"> Top 5 Risk Off Stocks That May Plunge This Quarter</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 0.7% to $77.44 while gold traded down 0.1% at $2,184.20.
Silver traded up 0.3% to $24.615 on Monday while copper rose 0.8% to $3.9220.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mostly lower today. The eurozone&rsquo;s STOXX 600 fell 0.4%, London&rsquo;s FTSE 100 fell 0.3% while Spain&rsquo;s IBEX 35 Index rose 0.1% The German DAX fell 0.6% French CAC 40 fell 0.2% while Italy&rsquo;s FTSE MIB Index fell 0.4%.
Spanish retail trade rose by 0.3% year-over-year in January versus a revised 2.7% gain in the previous month.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Monday, with Japan&rsquo;s Nikkei 225 dipping 2.19%, Hong Kong&rsquo;s Hang Seng Index gaining 1.43%, China&rsquo;s Shanghai Composite Index gaining 0.74% and India&rsquo;s S&amp;P BSE Sensex falling 0.81%.
Chinese vehicle sales dipped by 19.9% year-over-year to 1.58 million units in February versus a 47.9% surge in the prior month. Japanese machine tool orders declined by 8% year-over-year to JPY 114,154 million in February. Japan&#39;s GDP expanded by 0.1% quarter-over-quarter in the fourth quarter versus a 0.8% contraction in the third quarter.
&nbsp;
<h3>Economics</h3>
&nbsp;
No economic report of significance is due for Monday
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37578904/how-to-earn-500-a-month-from-calavo-growers-ahead-of-q1-earnings"> How To Earn $500 A Month From Calavo Growers Ahead Of Q1 Earnings</a>

US Stocks Down; Dow Falls 100 Points

Eltek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTK#NASDAQ">ELTK</a>) reported quarterly earnings of $0.22 per share which missed the analyst consensus estimate of $0.31 by 29.03 percent. This is a 57.14 percent increase over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $12.32 million which beat the analyst consensus estimate of $12.20 million by 0.99 percent. This is a 17.58 percent increase over sales of $10.48 million the same period last year.

Eltek Q4 EPS $0.22 Misses $0.31 Estimate, Sales $12.32M Beat $12.20M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; Ballard Power Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDP#NASDAQ">BLDP</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.
&bull; Endeavor Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDR#NYSE">EDR</a>) is likely to report quarterly earnings at $0.02 per share on revenue of $49.47 million.
&bull; SilverCrest Metals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SILV#AMEX">SILV</a>) is likely to report quarterly earnings at $0.10 per share on revenue of $44.09 million.
&bull; Global X Silver Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIL#NYSE">SIL</a>) is likely to report quarterly earnings at $0.10 per share on revenue of $44.09 million.
&bull; Legend Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEGN#NASDAQ">LEGN</a>) is projected to report quarterly loss at $0.83 per share on revenue of $86.52 million.
&bull; Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>) is projected to report earnings for its fourth quarter.
&bull; Overseas Shipholding Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSG#NYSE">OSG</a>) is expected to report earnings for its fourth quarter.
&bull; Eltek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTK#NASDAQ">ELTK</a>) is projected to report quarterly earnings at $0.31 per share on revenue of $12.20 million.
&bull; Endeavour Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXK#NYSE">EXK</a>) is estimated to report quarterly earnings at $0.02 per share on revenue of $49.47 million.
&bull; Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) is projected to report quarterly earnings at $0.24 per share on revenue of $775.89 million.
<h3>Companies Reporting After The Bell</h3>
&bull; Hesai Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) is likely to report quarterly loss at $0.11 per share on revenue of $81.11 million.
&bull; PLAYSTUDIOS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYPS#NASDAQ">MYPS</a>) is expected to report quarterly loss at $0.02 per share on revenue of $75.31 million.
&bull; Ocular Therapeutix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUL#NASDAQ">OCUL</a>) is estimated to report quarterly loss at $0.30 per share on revenue of $15.71 million.
&bull; Asana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $167.68 million.
&bull; Calavo Growers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVGW#NASDAQ">CVGW</a>) is projected to report quarterly earnings at $0.17 per share on revenue of $252.67 million.
&bull; Mission Produce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVO#NASDAQ">AVO</a>) is likely to report quarterly loss at $0.06 per share on revenue of $210.75 million.
&bull; Casey&#39;s General Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASY#NASDAQ">CASY</a>) is estimated to report quarterly earnings at $2.13 per share on revenue of $3.54 billion.
&bull; Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) is estimated to report quarterly earnings at $1.38 per share on revenue of $13.31 billion.
&bull; Cango (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANG#NYSE">CANG</a>) is estimated to report earnings for its fourth quarter.
&bull; Beachbody Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BODI#NYSE">BODI</a>) is estimated to report quarterly loss at $3.12 per share on revenue of $108.75 million.
&bull; Ranpak Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACK#NYSE">PACK</a>) is expected to report quarterly loss at $0.04 per share on revenue of $87.04 million.
&bull; Alto Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTO#NASDAQ">ALTO</a>) is expected to report quarterly loss at $0.08 per share on revenue of $292.76 million.
&bull; CytomX Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) is expected to report quarterly loss at $0.03 per share on revenue of $21.04 million.
&bull; Yalla Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YALA#NYSE">YALA</a>) is expected to report earnings for its fourth quarter.
&bull; Assertio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASRT#NASDAQ">ASRT</a>) is projected to report quarterly loss at $0.02 per share on revenue of $33.81 million.
&bull; Smart Sand (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SND#NASDAQ">SND</a>) is expected to report quarterly loss at $0.06 per share on revenue of $57.70 million.
&bull; Bowman Consulting Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWMN#NASDAQ">BWMN</a>) is likely to report quarterly loss at $0.07 per share on revenue of $90.66 million.
&bull; LifeMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFMD#NASDAQ">LFMD</a>) is projected to report quarterly loss at $0.14 per share on revenue of $40.49 million.
&bull; Invesco KBW NASDAQ Fintech UCITS ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEK#NASDAQ">FTEK</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $6.90 million.
&bull; NN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNBR#NASDAQ">NNBR</a>) is expected to report quarterly loss at $0.08 per share on revenue of $113.15 million.
&bull; Alpha Teknova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKNO#NASDAQ">TKNO</a>) is expected to report quarterly loss at $0.24 per share on revenue of $8.32 million.
&bull; Monroe Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRCC#NASDAQ">MRCC</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $16.56 million.
&bull; Vail Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) is estimated to report quarterly earnings at $5.98 per share on revenue of $1.15 billion.
&bull; NET Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>) is projected to report quarterly loss at $0.05 per share on revenue of $1.50 million.
&bull; Heritage Insurance Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRTG#NYSE">HRTG</a>) is expected to report quarterly earnings at $0.46 per share on revenue of $185.11 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ALTO

ASAN

ASRT

BLDP

The Beachbody Company, Inc. Class A Common Stock

BODI

BWMN

CANG

CASY

CTMX

CVGW

FTEK

FTRE

HRTG

HSAI

LEGN

LFMD

MRCC

MYPS

NNBR

NPWR

OCUL

ORCL

PACK

SILV

TKNO

YALA

Earnings Scheduled For March 11, 2024

Eltek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTK#NASDAQ">ELTK</a>) is set to give its latest quarterly earnings report on Monday, 2024-03-11. Here's what investors need to know before the announcement.
Analysts estimate that Eltek will report an earnings per share (EPS) of $0.31. 
Eltek bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.05, which was followed by a 10.67% increase in the share price the next day.
Here's a look at Eltek's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.31</td>
<td>0.20</td>
<td>0.13</td>
<td></td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.36</td>
<td>0.22</td>
<td>0.27</td>
<td>0.14</td>
</tr>
<tr>
<td>Price Change %</td>
<td>11.0%</td>
<td>4.0%</td>
<td>14.000000000000002%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1709910101_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Eltek were trading at $13.76 as of March 07. Over the last 52-week period, shares are up 219.1%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/ELTK/earnings">To track all earnings releases for Eltek visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Eltek Earnings Preview

AAOI

ADTN

AEIS

AKTS

AMKR

APLD

BIGC

BLZE

CALX

CETX

CEVA

COMM

Core Scientific, Inc. - Class A Common Stock

CORZ

DAVA

DELL

DIOD

DZSI

EBON

ENPH

EPAM

ERIC

FARO

FORM

FSLR

FSLY

GDYN

GLOB

INFN

INTC

IONQ

KEYS

LITE

LWLG

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MPWR

MVIS

NOVT

NTAP

OKTA

OSIS

PLXS

POWI

PRFT

PRSO

PRST

PSTG

QCOM

QIWI

RGTI

RMBS

SANM

SEDG

SKYT

SLAB

SMRT

SMTC

SNOW

SPCB

SWKS

SYNA

TTMI

TWLO

VIAV

VRNT

VSAT

WAVD

WEAV

WKEY

WOLF

ZBRA

Shares of several companies in the broader tech sector are trading lower as Treasury yields rise following a greater-than-expected increase in U.S. January inflation data.

Eltek announced the pricing of an underwritten public offering of 625,000 ordinary shares at&nbsp; a public offering price of&nbsp;$16.00&nbsp;per share, for gross proceeds of&nbsp;$10,000,000, before deducting underwriting discounts and offering expenses. All of the ordinary shares are being sold by the Company. The offering is expected to close on&nbsp;February 15, 2024, subject to satisfaction of customary closing conditions.&nbsp;

Reported Late Monday, Eltek Has Priced Its Public Offering Of 625,000 Ordinary Shares At $16 Per Share

General

Eltek Places $4.5M Of Purchase Orders For Machines, Software, And A Comprehensive Service Contract

Eltek Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTK#NASDAQ">ELTK</a>), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, announced today that it has received five purchase orders in a total amount of $3.8 million. The orders are in connection with two projects for a customer. Most of the orders will be supplied by Eltek during 2024.
"One of the projects is an existing legacy strategic project and the second project is new, with very high-technological specifications. We received this second project's order after providing successful proof of concept. The proof of the concept required us to meet a high level of technological production and the use of exotic materials. I am sure that the development of these capabilities will serve us in the future with additional orders that are at the cutting edge of technology," commented Eli Yaffe, CEO of Eltek.

Eltek Receives Five Purchase Orders Totaling $3.8M

Eltek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTK#NASDAQ">ELTK</a>) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.31 by 16.13 percent. This is a 111.76 percent increase over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $11.86 million which missed the analyst consensus estimate of $11.90 million by 0.33 percent. This is a 14.85 percent increase over sales of $10.33 million the same period last year.

Eltek Q3 EPS $0.36 Beats $0.31 Estimate, Sales $11.86M Miss $11.90M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; Children&#39;s Place (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLCE#NASDAQ">PLCE</a>) is projected to report quarterly earnings at $3.56 per share on revenue of $471.82 million.
&bull; Eltek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTK#NASDAQ">ELTK</a>) is estimated to report quarterly earnings at $0.31 per share on revenue of $11.90 million.
&bull; Borr Drilling (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BORR#NYSE">BORR</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $191.00 million.
&bull; Shoe Carnival (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCVL#NASDAQ">SCVL</a>) is likely to report quarterly earnings at $1.01 per share on revenue of $328.26 million.
&bull; Brady (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRC#NYSE">BRC</a>) is projected to report quarterly earnings at $0.93 per share on revenue of $340.92 million.
&bull; Alibaba Gr Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) is estimated to report quarterly earnings at $2.12 per share on revenue of $30.79 billion.
&bull; Spire (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SR#NYSE">SR</a>) is estimated to report quarterly loss at $0.66 per share on revenue of $315.88 million.
&bull; Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) is expected to report quarterly earnings at $1.41 per share on revenue of $149.82 billion.
&bull; BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) is projected to report quarterly earnings at $0.33 per share on revenue of $746.78 million.
&bull; Dole (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOLE#NYSE">DOLE</a>) is estimated to report quarterly earnings at $0.12 per share on revenue of $2.19 billion.
&bull; NetEase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTES#NASDAQ">NTES</a>) is expected to report quarterly earnings at $1.45 per share on revenue of $3.81 billion.
&bull; Youdao (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAO#NYSE">DAO</a>) is projected to report quarterly loss at $0.07 per share on revenue of $229.45 million.
&bull; Bath &amp; Body Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) is expected to report quarterly earnings at $0.35 per share on revenue of $1.56 billion.
&bull; Stratasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSYS#NASDAQ">SSYS</a>) is expected to report quarterly earnings at $0.03 per share on revenue of $162.54 million.
&bull; Allot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLT#NASDAQ">ALLT</a>) is likely to report quarterly loss at $0.27 per share on revenue of $23.13 million.
&bull; OneWater Marine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEW#NASDAQ">ONEW</a>) is estimated to report quarterly earnings at $0.64 per share on revenue of $416.40 million.
&bull; Atour Lifestyle Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATAT#NASDAQ">ATAT</a>) is estimated to report earnings for its third quarter.
&bull; Aurora Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) is estimated to report earnings for its third quarter.
&bull; Gogoro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GGR#NASDAQ">GGR</a>) is likely to report earnings for its third quarter.
&bull; Dingdong (Cayman) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDL#NYSE">DDL</a>) is estimated to report earnings for its third quarter.
&bull; Arcos Dorados Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARCO#NYSE">ARCO</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $1.11 billion.
&bull; Warner Music Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>) is estimated to report quarterly earnings at $0.25 per share on revenue of $1.58 billion.
&bull; Macy&#39;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) is likely to report quarterly earnings at $0.02 per share on revenue of $4.79 billion.
&bull; NICE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NICE#NASDAQ">NICE</a>) is projected to report quarterly earnings at $2.15 per share on revenue of $595.19 million.
&bull; Berry Global Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BERY#NYSE">BERY</a>) is estimated to report quarterly earnings at $2.11 per share on revenue of $3.15 billion.
<h3>Companies Reporting After The Bell</h3>
&bull; Globus Maritime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBS#NASDAQ">GLBS</a>) is projected to report earnings for its third quarter.
&bull; Zenvia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENV#NASDAQ">ZENV</a>) is estimated to report earnings for its third quarter.
&bull; Copart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NASDAQ">CPRT</a>) is estimated to report quarterly earnings at $0.32 per share on revenue of $990.66 million.
&bull; Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) is likely to report quarterly earnings at $1.48 per share on revenue of $544.65 million.
&bull; Haynes Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAYN#NASDAQ">HAYN</a>) is estimated to report quarterly earnings at $1.12 per share on revenue of $164.13 million.
&bull; American Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSWA#NASDAQ">AMSWA</a>) is estimated to report quarterly earnings at $0.09 per share on revenue of $28.00 million.
&bull; Qifu Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QFIN#NASDAQ">QFIN</a>) is projected to report quarterly earnings at $0.88 per share on revenue of $569.27 million.
&bull; voxeljet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VJET#NASDAQ">VJET</a>) is expected to report quarterly loss at $0.48 per share on revenue of $6.51 million.
&bull; Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) is expected to report quarterly earnings at $1.88 per share on revenue of $6.14 billion.
&bull; Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) is likely to report quarterly earnings at $1.31 per share on revenue of $765.35 million.
&bull; Post Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POST#NYSE">POST</a>) is expected to report quarterly earnings at $1.18 per share on revenue of $1.92 billion.
&bull; Matthews International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MATW#NASDAQ">MATW</a>) is likely to report quarterly earnings at $0.90 per share on revenue of $483.00 million.
&bull; Natural Grocers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGVC#NYSE">NGVC</a>) is projected to report quarterly earnings at $0.20 per share on revenue of $285.00 million.
&bull; Intchains Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) is projected to report earnings for its third quarter.
&bull; Ross Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) is estimated to report quarterly earnings at $1.21 per share on revenue of $4.82 billion.
&bull; Geospace Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEOS#NASDAQ">GEOS</a>) is projected to report earnings for its fourth quarter.
&bull; ESCO Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESE#NYSE">ESE</a>) is likely to report quarterly earnings at $1.22 per share on revenue of $266.27 million.
&bull; Beazer Homes USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BZH#NYSE">BZH</a>) is likely to report quarterly earnings at $1.39 per share on revenue of $627.29 million.
&bull; Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPS#NYSE">GPS</a>) is likely to report quarterly earnings at $0.18 per share on revenue of $3.61 billion.
&bull; Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) is likely to report quarterly earnings at $0.53 per share on revenue of $290.20 million.
&bull; UGI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UGI#NYSE">UGI</a>) is projected to report quarterly loss at $0.06 per share on revenue of $1.92 billion.
&bull; ZTO Express (Cayman) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZTO#NYSE">ZTO</a>) is projected to report quarterly earnings at $0.38 per share on revenue of $1.36 billion.
&bull; PagSeguro Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAGS#NYSE">PAGS</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $791.87 million.
&bull; Compass Minerals Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMP#NYSE">CMP</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $231.26 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

Comments

Eltek

Notizie

Ultime notizie per Eltek (NASDAQ:ELTK) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO